Abstract |
In vitro and in vivo studies have suggested that human complement component C5a plays a key role in neutrophil injury in the adult respiratory distress syndrome (ARDS). First, using leukocyte aggregometry, we demonstrated that the addition of a recently developed rabbit anti-human polyclonal antibody to C5a des arg to endotoxin-activated plasma prevented leukocyte aggregation in vitro. We then administered the anti-C5a des arg antibody to septic primates (Macaca fascicularis). Three groups of primates, control, septic, and anti-C5a antibody treated septic, were studied (n = 4 in each group). A 30-min infusion of Escherichia coli (1 X 10(10)/kg) resulted in severe sepsis and ARDS. Primates were killed 4 h after completion of the E. coli infusion. Septic animals not treated with anti-C5a antibody had 75% mortality (3/4), decreased oxygenation, severe pulmonary edema, and profound hypotension. Septic primates treated with anti-C5a antibodies did not die and did not develop decreased oxygenation (P less than 0.05) or increased extravascular lung water (P less than 0.05). They also had a marked recovery in their mean arterial blood pressure (P less than 0.05). This study demonstrates that treatment with rabbit anti-human C5a des arg antibodies attenuates ARDS and some of the systemic manifestations of sepsis in nonhuman primates.
|
Authors | J H Stevens, P O'Hanley, J M Shapiro, F G Mihm, P S Satoh, J A Collins, T A Raffin |
Journal | The Journal of clinical investigation
(J Clin Invest)
Vol. 77
Issue 6
Pg. 1812-6
(Jun 1986)
ISSN: 0021-9738 [Print] United States |
PMID | 3711336
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies
- Complement C5
- Complement C5a, des-Arginine
- Complement C5a
|
Topics |
- Animals
- Antibodies
(analysis)
- Blood Pressure
- Cell Aggregation
- Complement C5
(analogs & derivatives, immunology)
- Complement C5a
- Complement C5a, des-Arginine
- Heart Rate
- Leukocytes
(cytology)
- Macaca fascicularis
- Pulmonary Wedge Pressure
- Respiratory Distress Syndrome
(complications, immunology)
- Sepsis
(complications)
- Vascular Resistance
|